Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2289]

Novel targeting in acute myeloid leukaemia

Prof Giovanni Martinelli - University of Bologna, Bologna, Italy

Novel targeting in acute myeloid leukaemia ( Prof Giovanni Martinelli - University of Bologna, Bologna, Italy )

Personalised medicine in Europe needs to be accessible to all

Prof Mark Lawler - Queen's University Belfast, Belfast, UK

Personalised medicine in Europe needs to be accessible to all ( Prof Mark Lawler - Queen's University Belfast, Belfast, UK )

Treatment of acute lymphoblastic leukaemia by activation of patient's immune...

Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany

Treatment of acute lymphoblastic leukaemia by activation of patient's immune cells by a bispecific antibody ( Dr Nicola Gökbuget - Goethe University Frankfurt, Frankfurt, Germany )

Better understandings of gene mutations aid diagnostic tools in CLL

Dr Elías Campo - University of Barcelona, Barcelona, Spain

Better understandings of gene mutations aid diagnostic tools in CLL ( Dr Elías Campo - University of Barcelona, Barcelona, Spain )

LHRH analogue goserelin helps preserve fertility among women undergoing chemo...

Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA

LHRH analogue goserelin helps preserve fertility among women undergoing chemo for hormone receptor-negative breast cancer ( Dr Halle Moore - Taussig Cancer Institute, Cleveland, USA )

Investigating anticarcinogenic compounds as an alternative to chemo

Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy

Investigating anticarcinogenic compounds as an alternative to chemo ( Dr Bernardo Bonnani - European Institute of Oncology, Milan, Italy )

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second...

Prof Marc Peeters - University of Antwerp, Antwerp, Belgium

KRAS/NRAS and BRAF mutations in study of panitumumab plus FOLFIRI for second-line treatment of mCC ( Prof Marc Peeters - University of Antwerp, Antwerp, Belgium )

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for...

Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA

Comment: HPV-targeted adoptive T cell therapy may provide a new strategy for advanced cervical cancer ( Dr Steven O'Day - Beverly Hills Cancer Center, Los Angeles, USA )

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid...

Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France

Phase III SELECT trial shows lenvatinib to be effective in resistant thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )

Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute...

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany

$Blinatumomab shown to be beneficial in relapsed/refractory B-precursor acute lymphoblastic leukaemia ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )$

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck...

Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA

Lower-dose radiation safe for certain lower-risk, HPV-positive head and neck cancers ( Prof Anthony Cmelak - Vanderbilt-Ingram Cancer Center, Nashville, USA )

ASCO 2014 roundup

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

ASCO 2014 roundup ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )

More from ecancer